CoChat

Mechanisms involved in the side effects of glucocorticoids

SCHACKE, H · 2002 · Pharmacology & Therapeutics

The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.

Abstract

Glucocorticoids (GCs) represent the most important and frequently used class of anti-inflammatory drugs. While the therapeutic effects of GCs have been known and used for more than 50 years, major progress in discovering the underlying molecular mechanisms has only been made in the last 10-15 years. There is consensus that the desired anti-inflammatory effects of GCs are mainly mediated via repression of gene transcription. In contrast, the underlying molecular mechanisms for GC-mediated side effects are complex, distinct, and frequently only partly understood. Recent data suggest that certain side effects are predominantly mediated via transactivation (e.g., diabetes, glaucoma), whereas others are predominantly mediated via transrepression (e.g., suppression of the hypothalamic-pituitary-adrenal axis). For a considerable number of side effects, the precise molecular mode is either so far unknown or both transactivation and transrepression seem to be involved (e.g., osteoporosis). The differential molecular regulation of the major anti-inflammatory actions of GCs and their side effects is the basis for the current drug-finding programs aimed at the development of dissociated GC receptor (GR) ligands. These ligands preferentially induce transrepression by the GR, but only reduced or no transactivation. This review summarizes the current knowledge of the most important GC-mediated side effects from a clinical to a molecular perspective. The focus on the molecular aspects should be helpful in predicting the potential advantages of selective GR agonists in comparison to classical GCs.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0163-7258(02)00297-8

Cites

211 of 211 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 211 references

Cited by

See all 1,847

Metadata

Authors
SCHACKE, H.
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2002-10
Volume
96
Issue
1
Pages
23-43
ISSN
0163-7258 (ISSN-L)
OpenAlex
W1997103341
Cited by
1,847
References
209
Citations by year
2026: 40 · 2025: 78 · 2024: 94 · 2023: 87 · 2022: 80 · 2021: 95 · 2020: 120 · 2019: 98 · 2018: 94 · 2017: 90 · 2016: 118 · 2015: 97 · 2014: 102 · 2013: 88 · 2012: 116
FWCI
12.20
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
glucocorticoids, glucocorticoid adverse effects, glucocorticoid receptor, transcriptional activation, transrepression, transcriptional repression, anti-inflammatory mechanism, selective glucocorticoid receptor agonists, diabetes mellitus, glaucoma, hypothalamic-pituitary-adrenal axis, osteoporosis
MeSH terms
Animals, Anti-Inflammatory Agents, Atrophy, Mental Disorders, Diabetes Mellitus, Glaucoma, Glucocorticoids, Growth Disorders, Humans, Hypertension, Hypothalamo-Hypophyseal System, Immune System, Organ Specificity, Osteoporosis, Pituitary-Adrenal System, Receptors, Glucocorticoid, Skin, Steroids, Wound Healing, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms involved in the side effects of glucocorticoids. https://app.cochat.ai/papers/10.1016/s0163-7258(02)00297-8
The paper
SCHACKE, H. (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacology & Therapeutics. https://doi.org/10.1016/s0163-7258(02)00297-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.